Saturday, 04/07/2009

Skip navigation

Text Size: S L |

Working Here

Living in the Cambridge Area  |


At MedImmune Cambridge, we are committed to bringing improvements to patients lives and by harnessing innovation and scientific excellence we are inspired to work together to become one of the worlds leading biopharmaceutical companies.

  •  
  • MedImmune is part of the AstraZeneca group of companies, representing a major long-term strategic investment by AstraZeneca in novel biological therapeutics
  •  
  • We are situated on Granta Park, Cambridge, UK (see Granta Park website for travel options). MedImmune headquarters is located in Gaithersburg, Maryland, USA. Projects are run collaboratively across sites
  •  
  • MedImmune Cambridge employs around 370 staff
  •  
  • Our proprietary technology allows us to create antibody therapeutics that mimic the human immune system
  •  
  • We have extensive antibody libraries, currently incorporating more than 100 billion distinct antibodies, from which our scientists can rapidly isolate human antibodies to chosen molecules
  •  
  • MedImmune has a strong product pipeline that includes candidates developed independently, in collaboration with partners and by licensees
  •  
  • HUMIRA®, developed in collaboration with Abbott, is the first product from the UK biotechnology industry to achieve 'blockbuster status', with sales in 2005 of over US$1 billion and in 2007 of over US$3 billion